NEW YORK (GenomeWeb News) – Phthisis Diagnostics announced that it has signed a distribution deal covering India.

The deal with Genetix Biotech, headquartered in New Delhi, is the first distribution deal by Phthisis in Asia. Genetix, which has more than 30 distributors in India and Southeast Asia, will handle Phthisis' entire product line, including those in development, as part of the deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.